Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)
China · Delayed Price · Currency is CNY 30.07
-1.39 (-4.42%)
Jul 30, 2026, 3:00 PM CST
SHA:603139 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 52.7 | 107.71 | 97.6 | 163.75 | 226.27 | 203.96 |
Trading Asset Securities | 0.25 | 0.25 | 0.36 | 3.02 | 4.5 | 119.47 |
Cash & Short-Term Investments | 52.95 | 107.97 | 97.96 | 166.77 | 230.77 | 323.43 |
Cash Growth | -49.70% | 10.21% | -41.26% | -27.73% | -28.65% | 29.17% |
Accounts Receivable | 222.25 | 249.45 | 235.45 | 271.95 | 190.58 | 183.07 |
Other Receivables | 34.92 | 12.61 | 10.21 | 9.68 | 3.54 | 9.46 |
Receivables | 257.17 | 262.06 | 245.66 | 281.71 | 202.03 | 192.54 |
Inventory | 190.44 | 163.14 | 195.49 | 199.35 | 122.77 | 119.89 |
Other Current Assets | 54.71 | 56.74 | 59.86 | 60.4 | 25.36 | 30.73 |
Total Current Assets | 555.27 | 589.9 | 598.97 | 708.22 | 580.93 | 666.59 |
Property, Plant & Equipment | 870.8 | 928.96 | 961.91 | 982.35 | 948.09 | 827.93 |
Long-Term Investments | 42.79 | 42.69 | 51.37 | 91.45 | 120.11 | 177.93 |
Goodwill | 7.49 | 7.49 | 18.83 | 15.11 | 15.11 | 19.98 |
Other Intangible Assets | 85.69 | 86.29 | 99.25 | 103.29 | 112.84 | 122.09 |
Long-Term Deferred Tax Assets | 42.83 | 42.83 | 34.43 | 21.19 | 13.33 | 4.85 |
Long-Term Deferred Charges | 4.2 | 4.5 | 5.87 | 5.07 | 2.22 | 11.52 |
Other Long-Term Assets | 96.01 | 111.76 | 117.22 | 125.02 | 28.18 | 29.33 |
Total Assets | 1,705 | 1,814 | 1,888 | 2,052 | 1,822 | 1,860 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 378.18 | 449.69 | 230.11 | 259.31 | 155.55 | 171.65 |
Accrued Expenses | 9.7 | 21.17 | 26.74 | 34.1 | 20.98 | 13.62 |
Short-Term Debt | 193.45 | 280.92 | 191.54 | 212.18 | 95.12 | 25.85 |
Current Portion of Long-Term Debt | 195.59 | 113.66 | 95.48 | 172.69 | 32.53 | 61.36 |
Current Portion of Leases | - | 30.21 | 6.59 | 1.92 | 28.98 | 11.52 |
Current Income Taxes Payable | 13.06 | 2.32 | 3.96 | 3.85 | 2.63 | 3.5 |
Current Unearned Revenue | 20.53 | 7.23 | 6.21 | 5.69 | 7.95 | 13.36 |
Other Current Liabilities | 73.83 | 25.31 | 37.61 | 17.16 | 17.98 | 17.57 |
Total Current Liabilities | 884.33 | 930.51 | 598.25 | 706.92 | 361.72 | 318.42 |
Long-Term Debt | 177.37 | 246.02 | 332.27 | 282.05 | 386.34 | 393.01 |
Long-Term Leases | 20.49 | 26.07 | 5.94 | 2.58 | 0.88 | 3.65 |
Long-Term Unearned Revenue | 39.67 | 40.67 | 40.74 | 35.25 | 36.01 | 18.46 |
Long-Term Deferred Tax Liabilities | 2.17 | 2.17 | 3.73 | 5.01 | 10.8 | 11.65 |
Total Liabilities | 1,124 | 1,245 | 980.94 | 1,032 | 795.75 | 745.2 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 99.88 | 99.88 | 99.88 | 99.88 | 99.88 | 99.88 |
Additional Paid-In Capital | 412.11 | 412.11 | 412.01 | 412.02 | 412.02 | 412.02 |
Retained Earnings | 21.4 | 0.52 | 333.97 | 423.59 | 449.98 | 520.42 |
Comprehensive Income & Other | 12.42 | 12.42 | 11.47 | 13.74 | 11.85 | 14.36 |
Total Common Equity | 545.8 | 524.92 | 857.32 | 949.23 | 973.73 | 1,047 |
Minority Interest | 35.25 | 44.06 | 49.58 | 70.69 | 52.22 | 68.35 |
Shareholders' Equity | 581.05 | 568.98 | 906.9 | 1,020 | 1,026 | 1,115 |
Total Liabilities & Equity | 1,705 | 1,814 | 1,888 | 2,052 | 1,822 | 1,860 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 586.9 | 696.87 | 631.83 | 671.43 | 543.85 | 495.39 |
Net Cash (Debt) | -533.95 | -588.9 | -533.87 | -504.66 | -313.07 | -171.97 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -5.37 | -5.90 | -5.36 | -5.02 | -3.13 | -1.74 |
Filing Date Shares Outstanding | 99.88 | 99.88 | 99.88 | 99.88 | 99.88 | 99.88 |
Total Common Shares Outstanding | 99.88 | 99.88 | 99.88 | 99.88 | 99.88 | 99.88 |
Working Capital | -329.06 | -340.6 | 0.72 | 1.31 | 219.21 | 348.17 |
Book Value Per Share | 5.46 | 5.26 | 8.58 | 9.50 | 9.75 | 10.48 |
Tangible Book Value | 452.62 | 431.13 | 739.24 | 830.83 | 845.77 | 904.6 |
Tangible Book Value Per Share | 4.53 | 4.32 | 7.40 | 8.32 | 8.47 | 9.06 |
Buildings | - | 679.21 | 733.37 | 730.73 | 150.04 | 110.05 |
Machinery | - | 452.43 | 363.73 | 320.91 | 149.39 | 85.45 |
Construction In Progress | - | 14.45 | 23.88 | 61.57 | 744.8 | 710.79 |